Anke Kretz-Rommel

Direttore Tecnico/Scientifico/R&S presso Bird Rock Bio, Inc.

Consumer Services

Health Technology

Commercial Services

Posizioni attive di Anke Kretz-Rommel

Società	Posizione	Inizio	Fine
Bird Rock Bio, Inc. Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA.	Direttore Tecnico/Scientifico/R&S	27/08/2009	-

Società	Posizione	Inizio	Fine
Alexion Antibody Technologies Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases.	Corporate Officer/Principal	-	-

Swiss Federal Institute of Technology

Doctorate Degree

Distribuzione geografica

Stati Uniti	3
Svizzera	2

Posizioni

Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1
Doctorate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
Bird Rock Bio, Inc. Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA.	Health Technology
Alexion Antibody Technologies Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases.	Commercial Services